Inventor · disambiguated record
Daniel Snell
Also filed as: SNELL DANIEL
3 granted patents·4 pending applications·21 citations·filing 2012–2022
69Inventor score
Top patents by PatentIndex Score
7 records- 0192US11186638B2Anti-αβTCR antibodyGENZYME CORP·Filed 2018·Granted Nov 30, 2021·10 cites·11 claims
- 0280US10017573B2Anti-αβTCR antibodySNELL DANIEL·Filed 2012·Granted Jul 10, 2018·8 cites·12 claims
- 0376US11142575B2Methods for enhancing immunosuppressive therapy by multiple administration of αβTCR-binding polypeptideGENZYME CORP·Filed 2014·Granted Oct 12, 2021·3 cites·11 claims
- 0469US2022153841A1Anti-alphabetatcr antibodyGENZYME CORP·Filed 2021·Application pending·0 cites
- 0557US2022098299A1Methods for enhancing immunosuppressive therapy by multiple administration of alpha beta tcr-binding polypeptideGENZYME CORP·Filed 2021·Application pending·0 cites
- 0650US2024392003A1Multispecific antibodies having specificity for ror1 and cd3Numab Therapeutics AG·Filed 2022·Application pending·0 cites
- 0749US2023203162A1Multispecific antibodyNumab Therapeutics AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Snell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →